Prevalence of nosocomial infections at intensive care units in Turkey: A multicentre 1-day point prevalence study

References

• Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991; 91: 179–84.
   PubMed Web of Science ®Google Scholar
• Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The Second National Prevalence Survey of infection in hospitals: overview of the results. J Hosp Infect 1996; 32: 175–90.
   PubMed Web of Science ®Google Scholar
• Mayon-White RT, Ducel G, Kereselidze T, Tikomirov E. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect 1988; 11 (Suppl A): 43–8.
   Google Scholar
• Craven DE, Kunches LM, Lichtenberg DA, Kollisch NR, Barry MA, Heeren TC, McCabe WR. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988; 148: 1161–8.
   Google Scholar
• Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and paediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 185–91.
   Google Scholar
• Arman D. Turkiye’de hastane infeksiyonu kontrolune yonelik calismalar. Hastane Infeksiyonlari Dergisi 1997; 1: 144–52.
   Google Scholar
• Leblebicioglu H, Unal S. The organization of hospital infection control in Turkey. J Hosp Infect 2002; 51: 1–6.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections 1988. Am J Infect Control 1988; 16: 128–40.
   Google Scholar
• Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639–44.
   Google Scholar
• Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887–92.
   Google Scholar
• Legras A, Malvy D, Quinioux AI, Villers D, Bouachour G, Robert R, Thomas R. Nosocomial infections: prospective survey of incidence in 5 French intensive care units. Intensive Care Med 1998; 24: 1040–6.
   PubMed Web of Science ®Google Scholar
• Ponce de Leon-Rosales SP, Molinar-Ramos F, Dominguez-Cherit G, Rangel-Frausto MS, Vazquez-Ramos VG. Prevalence of infections in intensive care units in Mexico: a multicentre study. Crit Care Med 2000; 28: 1316–21.
   PubMed Web of Science ®Google Scholar
• Wenzel RP, Thompson RL, Landry SM, Russell BS, Miller PJ, Ponce DL, Miller GB Jr. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control 1983; 4: 371–5.
   Google Scholar
• Leblebicioglu H, Esen S. Hospital-acquired urinary tract infections in Turkey: a nationwide multicentre point prevalence study. J Hosp Infect 2003; 53: 207–10.
   PubMed Web of Science ®Google Scholar
• Aksaray S, Dokuzoguz B, Guvener E, Yucesoy M, Yulug N, Kocagoz S, et al. Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in 8 hospitals in Turkey. J Antimicrob Chemother 2000; 45: 695–9.
   PubMed Web of Science ®Google Scholar
• Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 2001; 32 (Suppl 2): 146–55.
   Google Scholar
• Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, Richet H. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998; 129: 182–9.
   Google Scholar
• Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995; 20: 790–6.
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Coskunkan F, Tansel O, Ozturk R, Sahin N, Koksal I, et al. Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol 200; 50: 642–5.
   Google Scholar
• Yuce A, Karaman M, Gulay Z, Yulug N. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis 2001; 33: 803–5.
   PubMed Web of Science ®Google Scholar
• Basustaoglu A, Aydogan H, Beyan C, Yalcin A, Unal S. First glycopeptide-resistant Enterococcus faecium isolate from blood culture in Ankara, Turkey. Emerg Infect Dis 2001; 7: 160–1.
   Google Scholar
• Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992; 15: 37–42.
   Web of Science ®Google Scholar